These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8933014)

  • 1. Assessing the evidence on aspirin in diabetes mellitus. Gemini or Libra; lumping or splitting; surrogate or hard; low or high; interventionist or nihilist.
    Yudkin JS
    Diabetologia; 1996 Nov; 39(11):1407-8. PubMed ID: 8933014
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes mellitus and peripheral vascular disease: is aspirin effective in preventing vascular events?
    Cimminiello C; Milani M
    Diabetologia; 1996 Nov; 39(11):1402-4. PubMed ID: 8933012
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy?
    Ceriello A; Motz E
    Diabetologia; 1996 Nov; 39(11):1405-6. PubMed ID: 8933013
    [No Abstract]   [Full Text] [Related]  

  • 4. Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
    Gresele P; Migliacci R
    Eur Heart J; 2004 Oct; 25(20):1769-71. PubMed ID: 15474690
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin and secondary prevention in peripheral artery disease: a perspective for the early 21st century.
    McDermott MM; Criqui MH
    JAMA; 2009 May; 301(18):1927-8. PubMed ID: 19436022
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for prevention of stroke and cardiovascular events among patients with peripheral artery disease.
    Takagi H; Umemoto T
    JAMA; 2009 Sep; 302(11):1165; author reply 1165-6. PubMed ID: 19755690
    [No Abstract]   [Full Text] [Related]  

  • 7. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myocardial infarct, stroke and vascular events reduced by a third].
    Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Underutilization of acetylsalicylic acid of cardiovascular prevention in patients with diabetes mellitus].
    Bueno H
    Med Clin (Barc); 2004 Jan; 122(3):101-3. PubMed ID: 14746700
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin for primary prevention of cardiovascular events in diabetes: still an open question.
    Nicolucci A
    JAMA; 2008 Nov; 300(18):2180-1. PubMed ID: 18997199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Should one prescribe aspirin for all diabetics?].
    Passa P
    Diabetes Metab; 1997 Dec; 23(6):554-6. PubMed ID: 9496565
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
    Le Dévéhat C; Khodabandehlou T; Mosnier M
    Clin Hemorheol Microcirc; 2000; 22(3):197-204. PubMed ID: 10976713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for primary prevention of cardiovascular events in diabetes.
    Colwell JA
    Diabetes Care; 2003 Dec; 26(12):3349-50. PubMed ID: 14633827
    [No Abstract]   [Full Text] [Related]  

  • 14. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin in type 2 diabetes: is there any evidence base?
    Walsh M; Spurling G
    BMJ; 2008 Oct; 337():a1902. PubMed ID: 18927174
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus.
    Rhee SY; Kim YS; Chon S; Oh S; Woo JT; Kim SW; Kim JW
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e11-4. PubMed ID: 20934769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and clopidogrel resistance in patients with diabetes mellitus.
    Scheen AJ; Legrand D
    Eur Heart J; 2006 Dec; 27(23):2900; author reply 2900-1. PubMed ID: 17015405
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
    Legrand DA; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.
    Bhatt DL; Marso SP; Hirsch AT; Ringleb PA; Hacke W; Topol EJ
    Am J Cardiol; 2002 Sep; 90(6):625-8. PubMed ID: 12231089
    [No Abstract]   [Full Text] [Related]  

  • 20. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG; Coccheri S; Marubini E; Violi F;
    Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.